Domi; Arban

Patent Applications and Registrations

Patent applications and USPTO patent grants for Domi; Arban.The latest application filed is for "cancer vaccine compositions and methods for use thereof".

Company Profile

9.8.18

Domi; Arban - Atlanta GA
Domi; Arban - Sandy Springs GA
Domi; Arban - New York NY
Domi; Arban - Parsippany NJ
Domi; Arban - Rockville MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Vaccinia viral vectors encoding chimeric virus like particles Grant 11,413,341 - Robinson , et al. August 16, 2	2022-08-16
Cancer Vaccine Compositions And Methods For Use Thereof App 20220160853 - Guirakhoo; Farshad ; et al.	2022-05-26
Replication-deficient Modified Vaccinia Ankara (mva) Expressing Marburg Virus Glycoprotein (gp) And Matrix Protein (vp40) App 20220152190 - Robinson; Harriett ; et al.	2022-05-19
Compositions and methods for generating an immune response to treat or prevent malaria Grant 11,311,612 - Guirakhoo , et al. April 26, 2	2022-04-26
Compositions And Methods For Generating An Immune Response To Hepatitis B Virus App 20220118082 - Guirakhoo; Farshad ; et al.	2022-04-21
Compositions and methods for generating an immune response to a tumor associated antigen Grant 11,278,607 - Robinson , et al. March 22, 2	2022-03-22
Compositions and methods for generating an immune response to hepatitis B virus Grant 11,052,148 - Guirakhoo , et al. July 6, 2	2021-07-06
Compositions and Methods for Generating an Immune Response to a Flavivirus App 20210100891 - Guirakhoo; Farshad ; et al.	2021-04-08
Vaccinia Viral Vectors Encoding Chimeric Virus Like Particles App 20200289633 - Robinson; Harriet ; et al.	2020-09-17
Compositions and Methods for Generating an Immune Response to Treat or Prevent Malaria App 20200282036 - Guirakhoo; Farshad ; et al.	2020-09-10
Compositions and Methods for Generating an Immune Response to LASV App 20200171141 - Guirakhoo; Farshad ; et al.	2020-06-04
Compositions and Methods for Generating an Immune Response to a Tumor Associated Antigen App 20190290745 - Robinson; Harriet ; et al.	2019-09-26
Compositions and Methods for Generating an Immune Response to Hepatitis B Virus App 20190184009 - Guirakhoo; Farshad ; et al.	2019-06-20
Compositions and Methods for Generating an Immune Response to a Hemorrhagic Fever Virus App 20190117758 - Robinson; Harriet Latham ; et al.	2019-04-25
Compositions and Methods for Generating an Immune Response to a Flavivirus App 20190030157 - Guirakhoo; Farshad ; et al.	2019-01-31
Neutralization-resistant CDV mutants and viral vectors Grant 10,081,796 - Zhang , et al. September 25, 2	2018-09-25
Methods to improve vector expression and genetic stability Grant 9,944,935 - Parks , et al. April 17, 2	2018-04-17
Genetically Stable Replication Competent Sendai Virus Vector(s) Containing And Expressing Optimized Hiv Genes App 20170258890 - Coleman; John ; et al.	2017-09-14
Methods To Improve Vector Expression And Genetic Stability App 20160222392 - Parks; Christopher L. ; et al.	2016-08-04
Novel Cdv Vector Membrane Glycoprotein Variants App 20160201087 - Zhang; Xinsheng ; et al.	2016-07-14
Methods to improve vector expression and genetic stability Grant 9,347,065 - Parks , et al. May 24, 2	2016-05-24
Methods To Improve Vector Expression And Genetic Stability App 20130266989 - Parks; Christopher L. ; et al.	2013-10-10
VAC-BAC shuttle vector system Grant 7,494,813 - Moss , et al. February 24, 2	2009-02-24
VAC-BAC shuttle vector system App 20050124070 - Moss, Bernard ; et al.	2005-06-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.